News | Coronavirus (COVID-19) | June 18, 2020

 

Researchers from five infectious disease hospitals across four districts in Guangzhou, China found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial reverse transcription–polymerase chain reaction (RT-PCR) results for 21 patients (nine men, 12 women; age range, 26–90 years)

Researchers from five infectious disease hospitals across four districts in Guangzhou, China found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial reverse transcription–polymerase chain reaction (RT-PCR) results for 21 patients (nine men, 12 women; age range, 26–90 years)

Comparison of CT features between groups with negative and positive initial RT-PCR results.
aThe difference was statistically significant in comparison of the two groups (p < 0.05).


June 18, 2020 — An open-access American Journal of Roentgenology (AJR) article exploring the diagnostic value of chest computed tomography (CT)  for coronavirus disease (COVID-19) pneumonia — especially for patients with negative initial results of reverse transcription–polymerase chain reaction (RT-PCR) testing — found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial RT-PCR results.

From January 19 to February 20, 2020, lead investigator Dandan Chen of Guangzhou First People’s Hospital in China obtained the admission data of 21 patients (nine men, 12 women; age range, 26–90 years) with confirmed COVID-19 pneumonia from five nonspecialized infectious disease hospitals across Guangzhou.

After undergoing chest CT and swab RT-PCR tests within 3 days, patients were divided into two groups: seven patients with negative initial results (who were found to have positive results after a second RT-PCR test 2 days later) and 14 patients with initial positive results.

“Most of the COVID-19 lesions were located in multiple lobes (67%) in both lungs (72%) in our study,” Chen et al. wrote, adding that the CT findings observed most frequently were ground-glass opacities (95%) and consolidation (72%) with subpleural distribution (100%). “Otherwise,” they continued, “33% of patients had other lesions around the bronchovascular bundle.”

Additional chest CT findings identified by Chen and colleagues included air bronchogram (57%), vascular enlargement (67%), interlobular septal thickening (62%), and pleural effusions (19%).

Ultimately, compared with the positive initial RT-PCR results group, CT of the group with negative initial RT-PCR results was less likely to indicate pulmonary consolidation (p < 0.05).

Acknowledging that RT-PCR detection can be affected by laboratory reagents, test method, and subjective operability, Chen noted that, theoretically, the multicenter nature of this study—five hospitals in four districts of Guangzhou (13 cases in Huadu, four in Baiyun, three in Yuexiu, one in Nansha)—should have reduced interference by such factors.
“When patients with suspected COVID-19 pneumonia who have an epidemiologic history and typical CT features have negative initial RT-PCR results,” the authors of this AJR article concluded, “repeated RT-PCR tests and patient isolation should be considered.”

For more information: www.ajronline.com


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
News | Radiology Education

July 19, 2024 — Core tactics to address the current medical imaging and radiation therapy workforce shortage and build ...

Time July 19, 2024
arrow
News | Computed Tomography (CT)

July 18, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 18, 2024
arrow
News | Digital Radiography (DR)

July 18, 2024 — At the Annual Meeting of AHRA (the Association for Medical Imaging Management), Agfa Radiology Solutions ...

Time July 18, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
Subscribe Now